Foghorn Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Foghorn Therapeutics Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Cambridge
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: FHTX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001822462

Board of directors

Follow this board

Adam Koppel · Director
Since 2023
Adrian Gottschalk · Director · Chief Executive Officer
Since 2023
B. Lynne Parshall · Director
Since 2023
Douglas G. Cole · Director
Since 2023
Ian F. Smith · Director
Since 2023
Michael Mendelsohn · Director
Since 2023
Neil Gallagher · Director
Since 2025
Noubar Afeyan · Director
Since 2026
Scott Biller · Director
Since 2023
Simba Gill · Director
Since 2023
Stuart Duty · Director
Since 2025
Thomas J. Lynch Jr. · Director
Since 2023

Chief executives

Adrian Gottschalk · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 16 other boards. 15 are in the same sector.

Shared director Other board Same sector

Solid Biosciences Inc. Same sector
via Adam Koppel and Ian F. Smith
Achieve Life Sciences Inc. Same sector
via Stuart Duty
Cytokinetics Incorporated Same sector
via B. Lynne Parshall
Denali Therapeutics Inc. Same sector
via Douglas G. Cole
EyePoint Inc.
via Stuart Duty
Generate Biomedicines Inc. Same sector
via Noubar Afeyan
Ionis Pharmaceuticals Inc. Same sector
via B. Lynne Parshall
Kailera Therapeutics Inc. Same sector
via Adam Koppel
Milestone Pharmaceuticals Inc. Same sector
via Stuart Duty
Moderna Inc. Same sector
via Noubar Afeyan
Natera Inc. Same sector
via Thomas J. Lynch Jr.
Odyssey Therapeutics Inc. Same sector
via Ian F. Smith
Sana Biotechnology Inc. Same sector
via Douglas G. Cole
Serina Therapeutics Inc. Same sector
via Simba Gill
Stoke Therapeutics Inc. Same sector
via Ian F. Smith
Zymeworks Inc. Same sector
via Neil Gallagher

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Apr 10, 2026	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	−59,208	—	—
Apr 10, 2026	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	+59,208	—	—
Apr 9, 2026	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	−47,497	—	—
Apr 9, 2026	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	+47,497	—	—
Apr 25, 2025	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	−300,000	—	—
Apr 25, 2025	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	+300,000	—	—
Apr 9, 2025	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	−197,906	—	—
Apr 9, 2025	Adrian Gottschalk Director, Officer (Chief Executive Officer)	Gift	+197,906	—	—
Sep 23, 2024	Costa Carlos Officer (Chief People Officer)	Option exercise	+857	$3.72	$3,188
Sep 23, 2024	Costa Carlos Officer (Chief People Officer)	Open-market sale	−857	$10.17	$8,716
Sep 20, 2024	Costa Carlos Officer (Chief People Officer)	Option exercise	+35,756	$3.72	$133,012
Sep 20, 2024	Costa Carlos Officer (Chief People Officer)	Open-market sale	−35,756	$10.04	$358,990
Sep 18, 2024	Costa Carlos Officer (Chief People Officer)	Option exercise	+11,574	$3.72	$43,055
Sep 18, 2024	Costa Carlos Officer (Chief People Officer)	Open-market sale	−11,574	$10.05	$116,319
Sep 17, 2024	Costa Carlos Officer (Chief People Officer)	Option exercise	+10,272	$3.72	$38,212

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Foghorn Therapeutics Inc.

Who is the CEO of Foghorn Therapeutics Inc.?

Adrian Gottschalk is Foghorn Therapeutics Inc.'s Chief Executive Officer.

How many directors are on Foghorn Therapeutics Inc.'s board?

Foghorn Therapeutics Inc.'s board has 12 directors: Adam Koppel, Adrian Gottschalk, B. Lynne Parshall, Douglas G. Cole, Ian F. Smith, Michael Mendelsohn, Neil Gallagher, Noubar Afeyan, Scott Biller, Simba Gill and 2 others.

How is Foghorn Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="foghorn-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.